Studies trying to understand the biochemical changes affecting fibrosis irreversibility have pinpointed LOXL2 as a key fibrogenic enzyme in liver fibrosis of various etiologies (3, 6, 8–10). This evidence concerns the gene LOXL2 and Hepatic fibrosis.